文献速递乳腺MR

背景实质强化的定量指标可预测乳腺癌风险

Quantitative Measures of Background Parenchymal Enhancement Predict Breast Cancer Risk.
PubMed 文献 · AJR Am J Roentgenol · 2020-09-02

本回顾性病例对照研究纳入95例无乳腺癌个人史的高危女性,其中19例后续发生乳腺癌,每例按年龄匹配4例对照。采用半自动分割算法计算定量背景实质强化(BPE)指标,并与放射科医生主观BPE分类比较预测效能。第一增强期在30%和40%强化比阈值下的BPE%的AUC分别为0.85和0.84,显著高于BPE分类的AUC 0.62。

要点

  • 第一增强期30%阈值BPE%的AUC为0.85,显著高于放射科医生BPE分类的AUC 0.62(P=.0007)。
  • 第一增强期40%阈值BPE%的AUC为0.84,同样显著高于BPE分类(P=.0004)。
  • BPE分类阈值大于轻微时区分病例与对照的AUC最大,为0.62。

关键影像表现/征象

  • 后续诊断为乳腺癌的女性更常见轻度、中度或显著BPE(OR 3.0,95%CI 0.9-10.0,P=.07)。
  • BPE分类阈值大于轻微时,区分病例与对照的AUC最大,为0.62。
  • 第一增强期30%强化比阈值BPE%的AUC为0.85,显著高于BPE分类(P=.0007)。
  • 第一增强期40%强化比阈值BPE%的AUC为0.84,显著高于BPE分类(P=.0004)。
  • 特征组合的AUC与单特征相近,但敏感度提高。

诊断标准与关键数值

  • 定量BPE%定义为各钆增强期相上超过强化比阈值(0-100%)的强化体素相对全乳腺体积的百分比。
  • BPE分类阈值大于轻微时区分病例与对照的AUC最大,为0.62。
  • 第一增强期30%强化比阈值BPE%的AUC为0.85(P=.0007 vs BPE分类)。
  • 第一增强期40%强化比阈值BPE%的AUC为0.84(P=.0004 vs BPE分类)。

临床应用与阅片要点

  • 定量BPE指标(尤其第一增强期30%-40%阈值BPE%)可能比主观BPE分类更好地预测后续乳腺癌风险。
  • 作者认为,纳入定量BPE指标的未来风险预测模型值得进一步研究。

局限性

  • 原文结论称初步数据,并指出纳入定量指标的未来风险预测模型值得进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Higher categories of background parenchymal enhancement (BPE) increase breast cancer risk. However, current clinical BPE categorization is subjective. OBJECTIVE. Using a semiautomated segmentation algorithm, we calculated quantitative BPE measures and investigated the utility of individual features and feature pairs in significantly predicting subsequent breast cancer risk compared with radiologist-assigned BPE category. METHODS. In this retrospective case-control study, we identified 95 women at high risk of breast cancer but without a personal history of breast cancer who underwent breast MRI. Of these women, 19 subsequently developed breast cancer and were included as cases. Each case was age matched to four control patients (76 control patients total). Sociodemographic characteristics were compared between the cases and matched control patients using the Mann-Whitney U test. From each dynamic contrast-enhanced MRI examination, quantitative fibroglandular tissue and BPE measures were computed by averaging enhancing voxels above enhancement ratio thresholds (0-100%), totaling the enhancing volume above thresholds (BPE volume in cm3), and estimating the percentage of enhancing tissue above thresholds relative to total breast volume (BPE%) on each gadolinium-enhanced phase. For the 91 imaging features generated, we compared predictive performance using conditional logistic regression with 80:20 hold-out cross validation and ROC curve analysis. ROC AUC was the figure of merit. Sensitivity, specificity, PPV, and NPV were also computed. All feature pairs were exhaustively searched to identify those with the highest AUC and Youden index. A DeLong test was used to compare predictive performance (AUCs). RESULTS. Women subsequently diagnosed with breast cancer were more likely to have mild, moderate, or marked BPE (odds ratio, 3.0; 95% CI, 0.9-10.0; p = .07). According to ROC curve analysis, a BPE category threshold greater than minimal resulted in a maximized AUC (0.62) in distinguishing cases from control patients. Compared with BPE category, the first gadolinium-enhanced (phase 1) BPE% at the 30% and 40% enhancement ratio thresholds yielded significantly higher AUC values of 0.85 (p = .0007) and 0.84 (p = .0004), respectively. Feature combinations showed similar AUC values with improved sensitivity. CONCLUSION. Preliminary data indicate that quantitative BPE measures may outperform radiologist-assigned category in breast cancer risk prediction. CLINICAL IMPACT. Future risk prediction models that incorporate quantitative measures warrant additional investigation.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Niell BL, Abdalah M, Stringfield O, et al. Quantitative Measures of Background Parenchymal Enhancement Predict Breast Cancer Risk. AJR Am J Roentgenol. 2020. PMID: 32876474. doi:10.2214/AJR.20.23804

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。